MAIA Biotechnology, Inc.
MAIA
$2.54
$0.20018.55%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -23.40% | -7.77% | -2.32% | 10.75% | 25.23% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.98% | 1.84% | 5.28% | 17.91% | 24.77% |
| Operating Income | 15.98% | -1.84% | -5.28% | -17.91% | -24.77% |
| Income Before Tax | -17.61% | -43.21% | -54.79% | -40.19% | -21.91% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.61% | -43.21% | -54.79% | -40.19% | -21.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.61% | -43.21% | -54.79% | -40.19% | -21.91% |
| EBIT | 15.98% | -1.84% | -5.28% | -17.91% | -24.77% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 24.98% | 5.74% | -2.04% | 4.19% | 15.63% |
| Normalized Basic EPS | 24.97% | 5.73% | -2.04% | 4.20% | 12.76% |
| EPS Diluted | 24.98% | 5.74% | -2.04% | 4.19% | 15.63% |
| Normalized Diluted EPS | 24.97% | 5.73% | -2.04% | 4.20% | 12.76% |
| Average Basic Shares Outstanding | 67.37% | 63.25% | 53.27% | 47.98% | 42.99% |
| Average Diluted Shares Outstanding | 67.37% | 63.25% | 53.27% | 47.98% | 42.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |